持续性肺部浸润影的评估

参考文献

关键文献

Menendez R, Perpina M, Torres A. Evaluation of non-resolving and progressive pneumonia. Semin Respir Infect. 2003 Jun;18(2):103-11. 摘要

Kuru T, Lynch JP 3rd. Non-resolving or slowly resolving pneumonia. Clin Chest Med. 1999 Sep;20(3):623-51. 摘要

El Solh AA, Aquilina AT, Gunen H, et al. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc. 2004 Feb;52(2):224-9. 摘要

Fein AM, Feinsilver SH, Niederman MS. Nonresolving or slowly resolving pneumonia: diagnosis and management in the elderly patient. Clin Chest Med. 1993 Sep;14(3):555-69. 摘要

Rome L, Murali G, Lippmann M. Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am. 2001 Nov;85(6):1511-30, xi. 摘要

Fein AM, Feinsilver SH. Non-resolving and slowly resolving pneumonia. In: Feinsilver SH, Fein AM, eds. Textbook of bronchoscopy. Baltimore, MD: Williams & Wilkins; 1995:286-301.

Menendez R, Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007 Oct;132(4):1348-55. 摘要

Woodhead M, Blasi F, Ewig S, et al; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011 Nov;17 (Suppl 6):E1-59.全文  摘要

Cassiere H, Rodrigues JC, Fein AM. Delayed resolution of pneumonia: when is slow healing too slow? Postgrad Med. 1996 Jan;99(1):151-4, 157-8. 摘要

Gross TJ, Chavis AD, Lynch JP 3rd. Noninfectious pulmonary diseases masquerading as community-acquired pneumonia. Clin Chest Med. 1991 Jun;12(2):363-93. 摘要

Lynch JP 3rd, Sitrin RG. Noninfectious mimics of community acquired pneumonia. Semin Respir Infect. 1993 Mar;8(1):14-45. 摘要

Low DE, Mazzulli T, Marrie T. Progressive and nonresolving pneumonia. Curr Opin Pulm Med. 2005 May;11(3):247-52. 摘要

Weyers CM, Leeper KV. Nonresolving pneumonia. Clin Chest Med. 2005 Mar;26(1):143-58. 摘要

参考文献

1. Menendez R, Perpina M, Torres A. Evaluation of non-resolving and progressive pneumonia. Semin Respir Infect. 2003 Jun;18(2):103-11. 摘要

2. Kuru T, Lynch JP 3rd. Non-resolving or slowly resolving pneumonia. Clin Chest Med. 1999 Sep;20(3):623-51. 摘要

3. Cunha BA. Slowly resolving and nonresolving pneumonias. Drugs Today (Barc). 2000 Dec;36(12):829-34. 摘要

4. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44 (Suppl 2):S27-72.全文  摘要

5. Mittl RL Jr, Schwab RJ, Duchin JS, et al. Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):630-5. 摘要

6. Orens JB, Sitrin RG, Lynch JP 3rd. The approach to nonresolving pneumonia. Med Clin North Am. 2004 Feb;52(2):224-9. 摘要

7. El Solh AA, Aquilina AT, Gunen H, et al. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc. 2004 Feb;52(2):224-9. 摘要

8. Fein AM, Feinsilver SH, Niederman MS. Nonresolving or slowly resolving pneumonia: diagnosis and management in the elderly patient. Clin Chest Med. 1993 Sep;14(3):555-69. 摘要

9. Eisenberg GM, Flippin HF, Israel HL, et al. Delayed resolution of pneumonias. Med Clin North Am. 1956 Sep;40(5):1291-303. 摘要

10. Kirtland SH, Winterbauer RH. Slowly resolving, chronic, and recurrent pneumonia. Clin Chest Med. 1991 Jun;12(2):303-18. 摘要

11. Rome L, Murali G, Lippmann M. Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am. 2001 Nov;85(6):1511-30, xi. 摘要

12. Fein AM, Feinsilver SH. Non-resolving and slowly resolving pneumonia. In: Feinsilver SH, Fein AM, eds. Textbook of bronchoscopy. Baltimore, MD: Williams & Wilkins; 1995:286-301.

13. Menendez R, Torres A, Zalacaín R, et al. Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004 Nov;59(11):960-5.全文  摘要

14. Menendez R, Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007 Oct;132(4):1348-55. 摘要

15. Woodhead M, Blasi F, Ewig S, et al; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011 Nov;17 (Suppl 6):E1-59.全文  摘要

16. Cassiere H, Rodrigues JC, Fein AM. Delayed resolution of pneumonia: when is slow healing too slow? Postgrad Med. 1996 Jan;99(1):151-4, 157-8. 摘要

17. Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med. 2000 Jul;162(1):154-60.全文  摘要

18. Gross TJ, Chavis AD, Lynch JP 3rd. Noninfectious pulmonary diseases masquerading as community-acquired pneumonia. Clin Chest Med. 1991 Jun;12(2):363-93. 摘要

19. Lynch JP 3rd, Sitrin RG. Noninfectious mimics of community acquired pneumonia. Semin Respir Infect. 1993 Mar;8(1):14-45. 摘要

20. Andrade CR, Ibiapina CC, Champs NS, et al. Avian influenza: the threat of the 21st century. J Bras Pneumol. 2009 May;35(5):470-9.全文  摘要

21. Low DE, Mazzulli T, Marrie T. Progressive and nonresolving pneumonia. Curr Opin Pulm Med. 2005 May;11(3):247-52. 摘要

22. Weyers CM, Leeper KV. Nonresolving pneumonia. Clin Chest Med. 2005 Mar;26(1):143-58. 摘要

23. Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med. 2005 May;11(3):203-7. 摘要

24. Kanmogne GD. Noninfectious pulmonary complications of HIV/AIDS. Curr Opin Pulm Med. 2005 May;11(3):208-12. 摘要

25. Shorr AF, Susla GM, O'Grady NP. Pulmonary infiltrate in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest. 2004 Jan;125(1):260-71. 摘要

26. Crawford S. Noninfectious lung disease in the immunocompromised host. Respiration. 1999;66(5):385-95.全文  摘要

27. Maschmeyer G, Carratalà J, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015 Jan;26(1):21-33.全文  摘要

28. Leone S, Nicastri E, Giglio S, et al. Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis. 2010 Apr;14(4):e283-91. 摘要

29. Teramoto S, Matsuse T, Ouchi Y. Foreign body aspiration into the lower airways may not be unusual in older adults. Chest. 1998 Jun;113(6):1733-4. 摘要

30. Spickard A 3rd, Hirschmann JV. Exogenous lipoid pneumonia. Arch Intern Med. 1994 Mar 28;154(6):686-92. 摘要

31. Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996 Feb 15;124(4):407-13. 摘要

32. Gluecker T, Capasso P, Schnyder P, et al. Clinical and radiologic features of pulmonary edema: a pictorial essay. Radiographics. 1999 Nov-Dec;19(6):1507-31.全文  摘要

33. Rudiger A, Gasser S, Fischler M, et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006 Aug;34(8):2140-4. 摘要

34. Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation. 2002 May 21;105(20):2328-31. 摘要

35. van Belle A, Buller HR, Huisman MV, et al; Writing Group for the Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006 Jan 11;295(2):172-9.全文  摘要

36. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med. 2006 Dec;119(12):1048-55. 摘要

37. Travis WD, Costabel U, Hansell DM, et al; on behalf of the ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial . Am J Respir Crit Care Med 2013 Sep 15;188(6):733-48.全文  摘要

38. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 Sep;40(9):1725. 摘要

39. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24. 摘要

40. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol. 1988 Feb;15(2):202-5. 摘要

41. Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl. 2001 Sep;32:56s-68s.全文  摘要

42. Infante PF, Newman LS. Beryllium exposure and chronic beryllium disease. Lancet. 2004 Feb 7;363(9407):415-6. 摘要

43. Begin R, Cantin A, Masse S. Recent advances in the pathogenesis and clinical assessment of mineral dust pneumoconioses: asbestosis, silicosis and coal pneumoconiosis. Eur Respir J. 1989 Nov;2(10):988-1001. 摘要

44. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004 Sep 15;170(6):691-715.全文  摘要

45. American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med. 1997 Feb;155(2):761-8. 摘要

46. Alberts WM. Eosinophilic interstitial lung disease. Curr Opin Pulm Med. 2004 Sep;10(5):419-24. 摘要

47. Allen JN, Magro CM, King MA. The eosinophilic pneumonias. Semin Respir Crit Care Med. 2002 Apr;23(2):127-34. 摘要

48. Loffler W. Transient lung infiltrations with blood eosinophilia. Int Arch Allergy Appl Immunol. 1956;8(1-2):54-9. 摘要

49. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med. 2006 Apr;27(2):192-7. 摘要

50. Zander DS. Allergic bronchopulmonary aspergillosis: an overview. Arch Pathol Lab Med. 2005 Jul;129(7):924-8.全文  摘要

51. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2003 Oct 15;168(8):952-8.全文  摘要

52. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med. 2004 Sep;25(3):531-47. 摘要

53. Silva CI, Churg A, Muller NL. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. AJR Am J Roentgenol. 2007 Feb;188(2):334-44.全文  摘要

54. Shah PL, Hansell D, Lawson PR, et al. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000 Jan;55(1):67-77.全文  摘要

55. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002 Jul 15;166(2):215-35.全文  摘要

56. Camus P, Bonniaud P, Fanton A, et al. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004 Sep;25(3):479-519. 摘要

57. Erasmus JJ, McAdams HP, Rossi SE. Drug-induced lung injury. Semin Roentgenol. 2002 Jan;37(1):72-81. 摘要

58. Camus P. Pneumotox online: the drug-induced respiratory disease website. Vol. 2, 2012 [internet publication].全文

59. Carver JR, Shapiro CL, Ng A, et al. ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007 Sep 1;25(25):3991-4008.全文  摘要

60. Writing committee members, Yancy CW, Jessup M, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct;128(16):e240-27.全文  摘要

61. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug 8;136(6):e137-61.全文  摘要

62. Centers for Disease Control and Prevention. Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis. Jan 2009 [internet publication].全文

63. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med. 2004 Sep;25(3):583-92. 摘要

64. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003 Feb 15;361(9357):587-94. 摘要

65. National Institute for Health and Care Excellence. Idiopathic pulmonary fibrosis in adults: diagnosis and management. June 2013 [internet publication].全文

66. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar;183(6):788-24.全文  摘要

67. Spicknall KE, Zirwas MJ, English JC 3rd. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005 Jun;52(6):1020-8. 摘要

68. Sordé R, Falcó V, Lowak M, et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med. 2011 Jan 24;171(2):166-72. 摘要

69. Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg 2017 Jun;153(6):e129-46. 摘要

70. Kearon C, Ginsberg JS, Douketis J, et al. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med. 2006 Jun 6;144(11):812-21. 摘要

71. Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 1998 Dec 15;129(12):997-1005. 摘要

72. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153-65.全文  摘要

73. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004 Dec;25(4):637-49. 摘要

74. Feinsilver SH, Fein AM, Niederman MS, et al. Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest. 1990 Dec;98(6):1322-6. 摘要

75. Detterbeck FC, Lewis SZ, Diekemper R, et al. Executive summary diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 May; 143(5 Suppl):7S–37S. 摘要

76. World Health Organization. WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection. Jun 2020 [internet publication].全文

77. Zifodya JS, Kreniske JS, Schiller I, et al. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Cochrane Database Syst Rev. 2021 Feb 22;(2):CD009593.全文  摘要

78. Shapiro AE, Ross JM, Yao M, et al. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms. Cochrane Database Syst Rev. 2021 Mar 23;(3):CD013694.全文  摘要

内容使用需遵循免责声明